Shopping Cart
Remove All
Your shopping cart is currently empty
Forodesine (BCX-1777) is an orally active and potent purine nucleoside phosphorylase (PNP) inhibitor, a new purine nucleoside analog, inhibitor of human lymphocyte proliferation, induces apoptosis in leukemic cells by increasing dGTP levels, and may be useful in the study of cutaneous T-cell lymphomas.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $59 | - | In Stock |
| Description | Forodesine (BCX-1777) is an orally active and potent purine nucleoside phosphorylase (PNP) inhibitor, a new purine nucleoside analog, inhibitor of human lymphocyte proliferation, induces apoptosis in leukemic cells by increasing dGTP levels, and may be useful in the study of cutaneous T-cell lymphomas. |
| Targets&IC50 | PNP (rat):1.24 nM, PNP (monkey ):0.66 nM, PNP (human):1.19 nM, PNP (dog):1.57 nM, PNP (mouse):0.48 nM |
| In vitro | Formodicin (10-30 μM; 24 and 48 hours; RPMI-8226, MOLT-4 and 5T33MM cells) has no effect on MM cells at 24 hours, but decreases the percentage of viable cells in MOLT-4 cells by 40% [1]. Treatment with forodosine (10-30 μM; 24 and 48 h; RPMI-8226, MOLT-4 and 5T33MM cells) partially inhibited cell proliferation [1]. In the presence of 2'-deoxyguanosine (dGuo, 3-10 μM), fordifloxacin inhibits the proliferation of human lymphocytes activated by a variety of drugs such as interleukin-2 (IL-2), mixed lymphocyte reaction (MLR) and phytohemagglutinin (PHA) (IC50 values less than 0.1-0.38 μM) [2]. |
| In vivo | Forodesine has excellent oral bioavailability (63%) in mice[2]. Forodesine(single dose of 10 mg/kg; in mice ) treatment, elevates dGuo to approximately 5 μM[2]. Forodesine is effective in prolonging the life span 2-fold or more, in the human peripheral blood lymphocyte severe combined immunodeficiency (hu-PBL-SCID) mouse model[2]. |
| Synonyms | Immucillin-H, BCX-1777 |
| Molecular Weight | 266.25 |
| Formula | C11H14N4O4 |
| Cas No. | 209799-67-7 |
| Smiles | OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)c1c[nH]c2c1nc[nH]c2=O |
| Relative Density. | 2.01 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (300.47 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (12.39 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.